Alta Bates Summit Medical Center receives shipment milestone - expanding their depth and breadth of Masimo SET and Masimo Rainbow SET technologies
IRVINE, Calif., Dec. 21 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI),
the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion
pulse oximetry, today announced that it has just shipped its 500,000th Masimo
SET bedside pulse oximeter (excluding hand-held units) to Alta Bates Summit
Medical Center, a Sutter Health network affiliate in Oakland and Berkeley,
California, as part of a five-year technology expansion agreement. Following
the conversion to Masimo SET pulse oximetry more than three years ago, Alta
Bates Summit Medical Center recently decided to expand the relationship by
adding more equipment and entering into a facility-wide site license for
Masimo Rainbow SET parameters. Also this year, Sutter Health established
Masimo SET as its system-wide standard for pulse oximetry.
Achieving 500,000 shipments highlights an increasing momentum in the
clinical adoption of Masimo SET as the "gold standard" in pulse oximetry.
Masimo's 200,000th shipment came in 2004, the eighth anniversary of Masimo SET
shipments. The 500,000th shipment was achieved less than four years later. The
growth comes as leading hospitals and health networks, like Alta Bates Summit
Medical Center and Sutter Health, have recognized the superior performance of
Masimo SET pulse oximetry and the clinical importance of the new, upgradeable
Masimo Rainbow SET technology platform as key building blocks in helping them
improve patient care and enhance patient safety initiatives.
Today, many of the world's leading hospitals have converted to Masimo SET
technology, including four of the top five as listed on the US News & World
Report Honor Roll, and over 50 monitoring brands have integrated Masimo SET
technology into their multiparameter monitor solutions.
Nancy E. Brosnan, R.N. CCRN, Critical Care Nurse Manager, Alta Bates
Summit Medical Center said, "We made the decision to move to Masimo SET pulse
oximetry more than three years ago because, quite simply, the Masimo
technology was a better than what was available at the time -- and it has
proven to be a very good product. The new capabilities of the Masimo Rainbow
SET platform will provide our clinicians with a powerful new set of
noninvasive measurements that will enable us to more effectively assess the
cardiopulmonary status of our patients on a continuous basis, facilitating
more expeditious treatment decisions that are inherently important to
enhancing patient safety and improving outcomes. We couldn't afford to ignore
this opportunity."
Alta Bates Summit Medical Center, a 1,094-bed not-for-profit medical
center with over 218,000 outpatient visits and more than 79,000 emergency
department visits annually, is a HealthGrades 2007 Distinguished Hospital
Award Winner for Clinical Excellence -- ranking among the top 5% in the nation
for overall clinical excellence. Sutter Health is one of the nation's leading
not-for-profit networks of community-based health care providers, delivering
high-quality care in more than 100 Northern California communities. It is also
the regional leader in infant deliveries, neonatology, orthopedics, pediatrics
and cancer care services. Sutter Health supports more than 26 not-for-profit
hospitals, as well as physician organizations; medical research facilities; a
region-wide home health, hospice and occupational health network; and
long-term care centers. A patient safety pioneer, Sutter Health network is
raising the bar on patient safety with a $1.2 billion network investment in a
broad range of patient safety initiatives over the next 10 years.
"Masimo SET is the right choice for our system-wide standard for pulse
oximetry," said Ian Leverton, M.D., Vice President, Sutter Health Clinical
Integration. "Masimo is an industry leader at the forefront of technology with
superior clinical performance, and it was available at a significant financial
savings."
Before the introduction of Masimo SET in 1995, pulse oximetry was reliable
only when patient conditions were ideal -- on motionless patients with strong
pulses and good perfusion. However, in the presence of patient motion, a weak
pulse or low perfusion, excessive false alarms rendered conventional pulse
oximetry virtually useless.
Since then, Masimo SET Read-Through Motion and Low Perfusion pulse
oximetry has become the new performance standard for leading hospitals like
Alta Bates and now Sutter Health -- making continuous, noninvasive monitoring
by pulse oximetry more reliable and clinically-relevant than ever before. As a
result, the industry has not only come to depend on continuous noninvasive
physiologic monitoring by Masimo SET pulse oximetry, but industry-leading
associations -- like The Joint Commission (JCAHO), American Society of
Anesthesiologists (ASA), and the Institute for Healthcare Improvement
(IHI) -- are now establishing industry standards for patient safety on general
care floors based on continuous pulse oximetry monitoring in combination with
appropriate clinician alerts and notification when physiologic conditions
change.
Today, Masimo Rainbow SET, an upgradeable noninvasive technology platform
featuring the accuracy and reliability of Masimo SET Read-Through Motion and
Low Perfusion pulse oximetry, is revolutionizing patient monitoring by
significantly expanding the ability to capture, track and monitor additional
blood constituents that previously required invasive procedures. The first and
only technology platform capable of continuously and noninvasively measuring
carboxyhemoglobin (SpCO(TM)),methemoglobin (SpMet(TM)) and, pleth variability
index (PVI), in addition to oxyhemoglobin (SpO2), perfusion index (PI) and
pulse rate, Masimo Rainbow SET is helping to advance patient safety and
improve care.
According to Charles Van Doren, Chief of Clinical Engineering at Alta
Bates Summit Medical Center, "When we first began to implement the Masimo
product into our facilities over three years ago in order to standardize
pulse-ox sensors, we found we were going from sensor standardization to
improving our patient care. At the same time we were replacing our
physiological monitors in our ICU's at the Summit campus we upgraded to
Masimo. Working together with the Nurse Managers, Material Management,
Clinical Engineering and Masimo Sales, we are now using only Masimo Technology
throughout the medical center. The new Rainbow SET technology platform will
allow us to grow as new technology becomes available."
Joe E. Kiani, Chairman and CEO of Masimo, stated "It is gratifying to see
how Masimo SET and Masimo Rainbow SET technologies are transforming the
clinical value and relevance of pulse oximetry by providing clinicians with a
solution they can depend on and grow with. Our 500,000th shipment is a
milestone that reflects the choices of the health care community -- from
clinicians who demand it and patient monitoring providers who work to
integrate it, to hospitals and health networks, like Alta Bates Summit Medical
Center and Sutter Health, that standardize on it -- Masimo technologies are
improving and saving lives. Alta Bates Summit Medical Center and Sutter Health
are exceptional medical organizations that set their sights high on patient
safety and we are proud to celebrate and share this milestone shipment with
them."
About Masimo
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that
significantly improve patient care -- helping solve "unsolvable" problems. In
1995, the company debuted Read-Through Motion and Low Perfusion pulse
oximetry, known as Masimo SET, and with it virtually eliminated false alarms
and increased pulse oximetry's ability to detect life-threatening events.
Masimo SET is the most accurate and reliable pulse oximetry technology,
clinically proven in more than 100 independent and objective studies to
provide the most trustworthy SpO2 and pulse rate measurements even under the
most difficult clinical conditions, including patient motion and low
peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET, a
breakthrough noninvasive blood constituent monitoring platform that can
measure many blood constituents that previously required invasive procedures.
Rainbow SET continuously and noninvasively measures carboxyhemoglobin (SpCO)
and methemoglobin (SpMet), pleth variability index (PVI), in addition to
oxyhemoglobin (SpO2), perfusion index (PI) and pulse rate, allowing early
detection and treatment of potentially life-threatening conditions. Founded in
1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost
of Care by Taking Noninvasive Monitoring to New Sites and Applications."
Additional information about Masimo and its products may be found at
http://www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Rainbow, SpCO, SpMet, PVI and Pulse CO-Oximeter are trademarks or registered
trademarks of Masimo Corporation.
SOURCE Masimo
CONTACT: Tom McCall of Masimo Corporation, +1-949-297-7075